MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 i 4500
001 in00005770132
005 20260327172732.9
006 m o d
007 cr n |||
008 180319s2019 paua ob 001 0 eng d
010 |z  2018013447 
040 |a COA  |b eng  |e rda  |c COA  |d OCLCO  |d OCLCF  |d OCLCO  |d OCLCQ  |d REDDC  |d SFB  |d OCLCL  |d OCLCQ  |d SMC  |d OCLCL  |d OCLCQ 
019 |a 1257368836  |a 1515273311 
020 |a 9780323533669 
020 |a 0323533663 
020 |a 0323568432 
020 |a 9780323568432 
024 8 |a (WaSeSS)ssj0002059350 
035 |a (OCoLC)1340059268  |z (OCoLC)1257368836  |z (OCoLC)1515273311 
050 1 0 |a RJ421  |b .H46 2019 
082 0 4 |a 618.92/12  |2 23 
049 |a TXAM 
130 0 |a Hemodynamics and cardiology (Online) 
245 1 0 |a Hemodynamics and cardiology :  |b neonatology questions and controversies /  |c [edited by] Istvan Seri ; consulting editor, Richard A. Polin. 
250 |a Third edition. 
264 1 |a Philadelphia, PA :  |b Elsevier, Inc.,  |c [2019] 
300 |a 1 online resource (xx, 612 pages :)  |b illustrations. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |2 rdaft 
490 1 |a Neonatology questions and controversies. 
500 |a Preceded by Hemodynamics and cardiology : neonatology questions and controversies / [edited by] Charles S. Kleinman, Istvan Seri ; consulting editor, Richard A. Polin. 2nd ed. c 2012. 
504 |a Includes bibliographical references and index. 
505 0 |a Front Cover -- IFC -- HEMODYNAMICS AND CARDIOLOGY: Neonatology Questions and Controversies -- Series Page -- HEMODYNAMICS AND CARDIOLOGY: Neonatology Questions and Controversies -- Copyright -- Contributors -- Preface -- Series Foreword -- Contents -- A -- Developmental Cardiovascular Physiology and Pathophysiology -- 1 -- Principles of Developmental Cardiovascular Physiology and Pathophysiology -- Principles of Developmental Physiology -- Fetal Circulation -- Transitional Physiology -- Postnatal Circulation -- Pressure, Flow, and Resistance -- Organ Blood Flow Distribution -- Microcirculatory Physiology (see Chapter 19) -- Myocardial Function-Developmental Aspects -- Developmental Cardiovascular Pathophysiology: Etiology and Pathophysiology of Neonatal Shock -- Definition and Phases of Shock -- Etiology of Neonatal Shock -- Hypovolemia -- Myocardial Dysfunction (see Chapter 26) -- Vasodilation -- Adrenal Insufficiency (see Chapter 30) -- Downregulation of Adrenergic Receptors -- Summary -- REFERENCES -- 2 -- Vascular Regulation of Blood Flow to Organs in the Preterm and Term Neonate -- Regulation of Arterial Tone -- The Role of Conduit Arteries in Regulating Vascular Resistance -- Arterial Reaction to Pressure (Autoregulation) -- Interaction of Autoregulation and Hypoxic Vasodilatation -- Interaction of Autoregulation and Pco2 -- Interaction of Autoregulation and Functional Activation (Metabolic Blood Flow Control) -- Flow-Mediated Vasodilatation -- Sympathetic Nervous System -- Humoral Factors in General Circulation -- Blood Flow to the Brain -- Autoregulation of Cerebral Blood Flow in the Immature Brain -- Effect of Carbon Dioxide on Cerebral Blood Flow -- Metabolic Control of Blood Flow to the Brain -- Adrenergic Mechanisms Affecting Cerebral Blood Flow -- Effect of Medications on Cerebral Blood Flow -- Ischemic Thresholds in the Brain. 
505 8 |a Blood Flow to Other Organs -- Kidney -- Liver -- Stomach and Intestines -- Distribution of Cardiac Output in the Healthy Human Neonate -- Blood Flow to the Upper Part of the Body -- Blood Flow to the Lower Part of the Body -- Mechanisms Governing the Redistribution of Cardiac Output in the Fetal "Diving" Reflex -- Aerobic Diving -- Reactions to Hypoxia -- Modifying Effects -- Distribution of Cardiac Output in the Shocked Newborn -- The Term Neonate With Low Cardiac Output -- The Very Preterm Neonate During Immediate Postnatal Adaptation -- Other Scenarios -- REFERENCES -- 3 -- Definition of Normal Blood Pressure Range: The Elusive Target -- Measuring Blood Pressure -- Blood Pressure Standards -- Clinical Factors Affecting Blood Pressure -- Antenatal Steroids -- Placental Transfusion -- Respiratory Support -- Blood Pressure and Short- and Long-Term Outcomes -- Bedside Clinical Assessment and Hemodynamic Monitoring -- Conclusion -- REFERENCES -- B -- Hemodynamic Principles of Postnatal Transition -- 4 -- Cardiorespiratory Effects of Delayed Cord Clamping -- The Transition to Newborn Life -- Airway Liquid Clearance -- Increase in Pulmonary Blood Flow at Birth in Response to Lung Aeration -- The Cardiovascular Transition at Birth: Effect of Umbilical Cord Clamping -- Neonatal Cardiovascular Responses to Umbilical Cord Clamping -- Neonatal Cardiovascular Consequences of Umbilical Cord Milking -- Placental Transfusion During Delayed Umbilical Cord Clamping -- Potential Mechanisms for Placental Blood Transfusion -- Gravity and Uterine Contraction -- Increase in Pulmonary Blood Flow at Birth -- Vaginal Birth -- Clinical Effects of Delayed/Deferred Umbilical Cord Clamping -- Potential Mechanisms of Benefit: Transfusion Versus Timing -- Determinants of the Placental Transfusion -- Time -- Position/Gravity -- Contractions/Oxytocics -- Mode of Delivery. 
505 8 |a Umbilical Blood Vessel Patency -- Breathing/Crying -- Prevention of Hypotension/Low Systemic Blood Flow -- Less Intervention at Birth: Resuscitation Versus Transitioning -- Physiologically Based Cord Clamping -- Conclusions -- REFERENCES -- 5 -- Hemodynamic Significance and Clinical Relevance of Delayed Cord Clamping and Umbilical Cord Milking -- Transitional Physiology and Animal Studies of Delayed Cord Clamping and Umbilical Cord Milking -- Cardiovascular Effects of Delayed Cord Clamping and Umbilical Cord Milking in the Delivery Room -- Hemodynamic Measurements in the First Hours After Birth Following Delayed Cord Clamping and Umbilical Cord Milking -- Neonatal Blood Volume After Delayed Cord Clamping and Umbilical Cord Milking -- Long-Term Outcomes and Mortality After Delayed Cord Clamping and Umbilical Cord Milking -- Conclusions and Future Directions -- REFERENCES -- 6 -- Transitional Hemodynamics and Pathophysiology of Peri/Intraventricular Hemorrhage -- Fetal and Transitional Circulation -- Cerebral Blood Flow -- Normal Changes in Cerebral Blood Flow -- Cerebral Blood Flow and Peri/Intraventricular Hemorrhage -- Vulnerabilities of Preterm Infants During Transition -- Inherent Vulnerability of the Immature Brain -- Immature Myocardium -- Hypovolemia and Timing of Cord Clamping -- Patent Ductus Arteriosus -- Hypotension -- Cardiorespiratory Interaction -- Hypocapnia and Hypercapnia -- Conclusions -- REFERENCES -- 7 -- The Immature Autonomic Nervous System, Hemodynamic Regulation, and Brain Injury in the Preterm Neonate -- Magnitude of the Problem -- Hemodynamic Vulnerability in Premature Infants -- The Premature Autonomic Nervous System -- The Premature Cardiovascular System -- Cerebral Hemodynamic Control in Premature Infants -- Evidence for an Association Between Systemic Hemodynamic Disturbances and Prematurity-Related Brain Injury. 
505 8 |a Resolving the Relationship Between Systemic Hemodynamics and Prematurity-Related Brain Injury: Obstacles to Progress -- Measurement of Relevant Hemodynamic and Metabolic Indices -- Potential for "Dysmaturation" of the Autonomic Nervous System in Premature Newborns -- Conclusion -- REFERENCES -- 8 -- Pathophysiology of Persistent Pulmonary Hypertension of the Newborn-Cellular Basis and Lessons from Animal Studies -- Physiology of the Fetal Circulation -- Low Placental Vascular Resistance -- High Fetal Pulmonary Vascular Resistance -- Transition at Birth -- Animal Models of Pulmonary Hypertension in the Newborn -- Antenatal Ductal Ligation Model in Sheep With Reduced Pulmonary Blood Flow -- Cellular and Biochemical Changes -- Aortopulmonary Graft With Pulmonary Overcirculation -- Cellular and Biochemical Changes -- Drug Induced Pulmonary Hypertension -- Meconium Aspiration Model -- Chronic Hypoxia -- Monocrotaline-Induced Pulmonary Hypertension in Rats -- Intrauterine Growth Restriction -- Congenital Diaphragmatic Hernia -- Fetal Surgical Model in Lambs -- Cellular and Biochemical Changes -- Nitrofen Model in Rats -- Cellular and Biochemical Abnormalities -- Medications in Pregnancy and Persistent Pulmonary Hypertension of the Newborn: Cellular Basis -- Selective Serotonin Reuptake Inhibitors -- Nonsteroidal Antiinflammatory Drugs -- Antenatal Betamethasone -- Free Radicals in Persistent Pulmonary Hypertension of the Newborn -- Oxidative Stress -- Reactive Nitrogen Species -- Pathological Vascular Remodeling in Persistent Pulmonary Hypertension of the Newborn -- Cellular and Biochemical Basis of Various Persistent Pulmonary Hypertension of the Newborn Therapies -- Oxygen -- Human Data on Hypoxic Pulmonary Vasoconstriction -- Inhaled Nitric Oxide -- Attenuating Inactivation of Inhaled Nitric Oxide by Superoxide. 
505 8 |a Soluble Guanylate Cyclase Stimulators and Activators (see Fig. 8.9) -- Inhibition of Phosphodiesterase 5 -- Hydrocortisone -- Inhibition of Phosphodiesterase 3 -- Cellular Basis for Emerging Therapies -- L-citrulline -- Rho-kinase inhibitors -- Stem Cell Therapies -- Conclusion -- Founding Sources -- REFERENCES -- 9 -- Pathophysiologically Based Management of Persistent Pulmonary Hypertension of the Newborn -- Pathophysiology, Hemodynamics and Treatment Targets -- Principles of Management of Persistent Pulmonary Hypertension of the Newborn -- Supportive Care -- Mechanical Ventilation and Surfactant -- Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn -- Oxygen and Carbon Dioxide -- Inhaled Nitric Oxide -- Role of Inhaled Nitric Oxide in Preterm Oxygenation Failure -- Weaning Inhaled Nitric Oxide -- Other Pulmonary/Systemic Vasodilators -- Phosphodiesterase-5 Inhibitors -- Phosphodiesterase-3 Inhibitors -- Prostaglandins -- Endothelin Receptor Antagonists -- Magnesium Sulfate -- Utilizing Pathophysiology to Guide the Use of Vasodilators in Persistent Pulmonary Hypertension of the Newborn -- Vasopressor Therapy in Persistent Pulmonary Hypertension of the Newborn -- Using Pathophysiology to Guide Use of Vasopressors in Persistent Pulmonary Hypertension of the Newborn -- Extracorporeal Membrane Oxygenation -- Conclusions -- REFERENCES -- C -- Diagnosis of Neonatal Cardiovascular Compromise: Methods and Their Clinical Applications -- C1 -- Assessment of Systemic Blood Flow and Cardiac Function: Ultrasound -- 10 -- Point of Care Ultrasound in the Assessment of the Neonatal Cardiovascular System -- Politics of Ultrasound -- What's in a Name? -- Training and Accreditation in Point of Care Ultrasound -- Using Physiology to Target Treatment -- Uses of Point of Care Ultrasound in the Neonatal Intensive Care Unit. 
650 0 |a Cardiovascular system  |x Diseases. 
650 0 |a Newborn infants. 
650 0 |a Newborn infants  |x Diseases. 
650 1 2 |a Cardiovascular Diseases 
650 2 2 |a Infant, Newborn 
650 2 2 |a Infant, Newborn, Diseases 
650 2 2 |a Neonatology  |x methods 
650 6 |a Appareil cardiovasculaire  |x Maladies. 
650 6 |a Nouveau-nés. 
650 6 |a Nouveau-nés  |x Maladies. 
650 7 |a Cardiovascular system  |x Diseases  |2 fast 
650 7 |a Newborn infants  |2 fast 
650 7 |a Newborn infants  |x Diseases  |2 fast 
655 7 |a Electronic books.  |2 local 
700 1 |a Seri, Istvan  |c (Pediatrician) 
700 1 |a Polin, Richard A.  |q (Richard Alan),  |d 1945- 
710 2 |a ScienceDirect (Online service) 
776 1 |z 0323533663 
830 0 |a Neonatology questions and controversies. 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/book/9780323533669  |z Connect to the full text of this electronic book  |t 0 
936 |a BATCHLOAD 
955 |a Elsevier ScienceDirect 2026-2027 
994 |a 92  |b TXA 
999 f f |i 1c7777e8-efdd-498e-9705-45271342fabb  |s 68950f9d-5d04-41a0-a10f-89d4c44f2a11  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |s www_evans  |d Available Online  |t 0  |e RJ421 .H46 2019  |h Library of Congress classification 
998 f f |a RJ421 .H46 2019  |t 0  |l Available Online